Luminist Capital’s Global Cord Blood Corporation CO Stock Holding History

Luminist Capital’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157	Buy	+165	New	+$157	﹤0.01%	396
2025 Q4	–	Sell	-165	Closed	-$165	–	270
2025 Q3	$165	Hold	165	–	–	﹤0.01%	328
2025 Q2	$239	Hold	165	–	–	﹤0.01%	328
2025 Q1	$157	Hold	165	–	–	﹤0.01%	244
2024 Q4	$248	Buy	+165	New	+$248	﹤0.01%	228

Other funds holding CO

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Luminist Capital's CO Position: Q2 2026 in Review

Luminist Capital opened a new position in Global Cord Blood Corporation (CO) in Q2 2026: 165 shares worth $157. The stake represents ﹤0.01% of the portfolio and ranks #396 among its holdings. This is a return to the name: Luminist Capital previously reported a position in CO as recently as Q3 2025.

Luminist Capital first reported a position in CO in Q4 2024 and has held it in 5 quarters since. The position peaked at $248 in Q4 2024. 2 funds tracked by Wall St. Rank hold CO as of Q2 2026.

Luminist Capital held 165 shares of Global Cord Blood Corporation worth $157 as of Q2 2026.
Global Cord Blood Corporation was a new Luminist Capital position in Q2 2026.
Global Cord Blood Corporation made up ﹤0.01% of Luminist Capital's portfolio in Q2 2026, its #396 holding.
Luminist Capital first reported a position in Global Cord Blood Corporation in Q4 2024 and has held it in 5 quarters since.
Luminist Capital's Global Cord Blood Corporation position peaked at $248 in Q4 2024.
2 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.